医疗机器人公司微创机器人-B(02252)今日盘中股价大涨9.61%,引发市场关注。公司订单量暴涨以及国际化业务加速推进,被视为股价走强的主要原因。
数据显示,微创机器人的多款手术机器人订单量集中释放。2024年,其图迈腹腔镜手术机器人全球订单达39台,商业化装机突破30台;鸿鹄骨科手术机器人全球订单25台;冠脉介入机器人R-ONE成为国内首款上市销售的手术机器人产品。公司总订单量已累计突破100台。
与此同时,微创机器人国际化进程正在加速推进。2024年11月,图迈机器人辅助国内专家完成上海至贝宁的远程手术,并于12月首次亮相欧洲,助力法国外科医生远程为摩洛哥患者实施手术。这标志着该公司正从国内走向国际舞台,国际增长潜力获市场认可。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.